From: VSTM-v1, a potential myeloid differentiation antigen that is downregulated in bone marrow cells from myeloid leukemia patients
Myeloblasts
Promyelocytes
Myelocytes
Metamyelocytes
CD markers
CD34+
CD34−, CD117+, CD16−
CD34−, CD117−, CD16−, CD13+
CD16+
VSTM1-v1-positive cells (%)
5.69 ± 2.69
11.48 ± 4.58
35.02 ± 11.58
61.63 ± 8.53
P valuea
<0.001